Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Clin Neuropharmacol. 2010 Jul;33(4):191–197. doi: 10.1097/WNF.0b013e3181de8966

Table 1.

MDD (n=27) No MDD (n=78) AA or AG (n=33) GG (n=72)
Gender (percent male) 66.7% 68.0% ns 72.7% 65.3% ns
Race (percent European-American) 85.2% 91.0% ns 78.8% 94.4% P=0.015
Age (years) 46.5 +/- 7.9 47.0 +/- 12.7 ns 45.7 +/- 10.6 47.4 +/- 12.2 ns
Weight (Kg) 87.0 +/- 13.7 86.5+/- 18.7 ns 85.4 +/- 15.3 87.2 +/- 18.4 ns
History of any mood disorder 48.2% 42.3% ns 36.4% 47.2% ns
History of drug or alcohol disorder 37.0% 33.3% ns 30.3% 36.1% ns

There were no statistically significant (ns) differences in demographics between subjects who developed major depressive disorder (MDD) and those who didn't. The A allele was more prevalent in self-identified African-Americans.